한글목차

심장유전체 검사 패널 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 15억 5,000만 달러에서 2026년에는 17억 5,000만 달러로, CAGR 12.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 심혈관 질환의 유병률 증가, 유전자 검사에 대한 접근성 제한, 유전성 심장질환에 대한 인식 개선, 기존 심혈관 진단 기술의 보급, 초기 시퀀싱 기술의 높은 비용 등의 요인에 기인하는 것으로 보입니다.

심장유전체 검사 패널 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 27억 8,000만 달러에 달하며, CAGR은 12.3%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 차세대 염기서열 분석(NGS) 기술 발전, 진단 분야에서의 AI와 바이오인포매틱스 통합, 정밀의료를 지원하는 정부 정책, 다유전자 패널 및 전체 엑솜 패널 채택 확대, 개인 맞춤형 심혈관 치료 수요 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향에는 개인화된 유전자 위험 프로파일링, AI 기반 진단 툴, 원격 심전도 진단 및 원격 모니터링, 다중 유전자 패널 통합, 고급 바이오인포매틱스 플랫폼 등이 포함됩니다.

유전성 심혈관 질환의 유병률 증가가 심장유전체 검사 패널 시장의 성장을 촉진할 것으로 예측됩니다. 유전성 심혈관질환(ICD)은 부모로부터 자식에게 유전적으로 물려받는 심장 및 혈관 질환을 말합니다. 유전자 검사와 진단기술의 발전으로 이전에는 확인할 수 없었던 질병을 보다 정확하게 검출할 수 있게 되어 진단 사례 증가에 기여하고 있습니다. 심장유전체 검사 패널은 유전성 심장질환을 유발하는 유전자 변이를 분석하여 조기 진단, 위험도 평가, 개인별 맞춤 치료 계획 수립을 돕습니다. 예를 들어 2025년 2월 영국의 지역 보건 센터인 Joint Strategic Needs Assessment가 발표한 보고서에 따르면 블랙풀에서는 2023년 185건의 심혈관 질환으로 인한 사망이 기록되며, 2022년 178건보다 증가했습니다. 증가했습니다. 이러한 증가 추세는 심장유전체 검사 패널 시장의 확대를 견인하고 있습니다.

의료비 지출 증가는 향후 수년간 심장유전체 검사 패널 시장의 성장을 촉진할 것으로 예측됩니다. 의료 지출은 정부, 민간단체, 개인이 의료 서비스 및 의료의 제공, 유지, 개선을 위해 지출하는 자금을 포함한 총 자원을 의미합니다. 의료비 증가는 주로 장기 치료, 지속적인 모니터링, 전문적인 의료 개입이 필요한 만성질환 증가에 기인합니다. 이 지출은 유전성 심혈관 질환을 조기에 발견하고 예방할 수 있는 고급 유전자 분석을 재정적으로 지원함으로써 환자 예후를 개선하고 장기적으로 비용을 절감할 수 있는 심장유전체 검사 패널을 지원하고 있습니다. 예를 들어 2024년 5월 영국 정부 기관인 국가통계청이 발표한 바에 따르면 2023년 의료 총 지출은 명목 기준으로 5.6% 증가하여 2022년 대비 0.9%의 성장을 기록했습니다. 그 결과, 의료비 증가가 심혈관 게놈 검사 패널 시장의 성장을 가속하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.

The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.

Tariffs are impacting the cardiogenomics testing panels market by increasing the cost of importing sequencing instruments, reagents, and consumables, particularly impacting regions such as North America, Europe, and Asia-Pacific where most advanced equipment is sourced from specialized suppliers. The resulting cost increase has slowed adoption in smaller diagnostic labs, while larger hospitals and academic institutes have mitigated the effect through local sourcing or partnerships. Positive impacts include incentivizing domestic manufacturing of certain testing kits and consumables, potentially reducing future dependency on imports and lowering costs over time.

The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.55 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, limited access to genetic testing, increasing awareness of inherited cardiac disorders, adoption of conventional cardiovascular diagnostic techniques, high cost of early sequencing technologies.

The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to advancements in next-generation sequencing (NGS), integration of ai and bioinformatics in diagnostics, government initiatives supporting precision medicine, growing adoption of multi-gene and whole exome panels, increasing demand for personalized cardiovascular care. Major trends in the forecast period include personalized genetic risk profiling, ai-driven diagnostic tools, tele-cardiology and remote monitoring, integration of multi-gene panels, advanced bioinformatics platforms.

The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.

The rising healthcare expenditure is anticipated to drive the expansion of the cardiogenomics testing panels market in the coming years. Healthcare expenditure encompasses the total resources, including funds spent by governments, private entities, and individuals, on providing, maintaining, and enhancing health services and medical care. The increase in healthcare spending is primarily attributed to the growing prevalence of chronic diseases that demand long-term treatment, continuous monitoring, and specialized medical interventions. This expenditure supports cardiogenomics testing panels by financing advanced genetic analyses that allow for the early detection and prevention of inherited cardiovascular diseases, thereby improving patient outcomes and lowering long-term costs. For example, in May 2024, the Office for National Statistics, a UK government department, reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, marking a 0.9% growth compared to 2022. Consequently, the rising healthcare expenditure fuels the growth of the cardiogenomics testing panels market.

In May 2025, GeneDx Inc., a US-based genetic testing company, completed the acquisition of Fabric Genomics Inc. for an undisclosed sum. Through this acquisition, GeneDx intends to enhance its genomic interpretation capabilities by incorporating Fabric Genomics' AI-powered variant interpretation platform, boosting scalability and diagnostic insights across its testing services. Fabric Genomics, Inc., a US-based genomics and bioinformatics firm, focuses on cardiogenomics testing panels and clinical genetic variant interpretation.

Major companies operating in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

North America was the largest region in the cardiogenomics testing panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiogenomics testing panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Testing Panels Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Single-Gene Panels; Multi-Gene Panels; Whole Exome Sequencing Panels
• 2) By Technology: Next-Generation Sequencing; PCR-Based Testing; Microarray; Other Technologies
• 3) By Application: Inherited Cardiovascular Diseases; Arrhythmias; Cardiomyopathies; Congenital Heart Diseases; Other Appications
• 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Single-Gene Panels: Ion Channel Gene Panels; Structural Heart Disease Gene Panels; Arrhythmia Gene Panels
• 2) By Multi-Gene Panels: Cardiomyopathy Panels; Arrhythmia Panels; Congenital Heart Disease Panels
• 3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels; Comprehensive Exome Panels; Research-Oriented Exome Panels
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Illumina Inc.; Actia Group; Invitae Corporation; Fulgent Genetics Inc.; GeneDx Inc.; Ambry Genetics Corporation; Helix OpCo Inc.; Centogene Gmbh; Blueprint Genetics Inc.; Strand Life Sciences Pvt. Ltd.; Genes2Me Pvt. Ltd.; BioAro Inc.; GENinCode Plc; Igenomix S.L.; Asper Biotech Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Cardiogenomics Testing Panels Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Cardiogenomics Testing Panels Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Cardiogenomics Testing Panels Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Cardiogenomics Testing Panels Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Personalized Genetic Risk Profiling
  • 4.2.2 Ai-Driven Diagnostic Tools
  • 4.2.3 Tele-Cardiology And Remote Monitoring
  • 4.2.4 Integration Of Multi-Gene Panels
  • 4.2.5 Advanced Bioinformatics Platforms

5. Cardiogenomics Testing Panels Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Diagnostic Laboratories
• 5.3 Academic And Research Institutes
• 5.4 Cardiology Centers
• 5.5 Specialized Genetic Testing Centers

6. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiogenomics Testing Panels Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Cardiogenomics Testing Panels Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiogenomics Testing Panels Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiogenomics Testing Panels Market Segmentation

• 9.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Single-Gene Panels, Multi-Gene Panels, Whole Exome Sequencing Panels
• 9.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing, PCR-Based Testing, Microarray, Other Technologies
• 9.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inherited Cardiovascular Diseases, Arrhythmias, Cardiomyopathies, Congenital Heart Diseases, Other Appications
• 9.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users
• 9.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ion Channel Gene Panels, Structural Heart Disease Gene Panels, Arrhythmia Gene Panels
• 9.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiomyopathy Panels, Arrhythmia Panels, Congenital Heart Disease Panels
• 9.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Targeted Cardiovascular Exome Panels, Comprehensive Exome Panels, Research-Oriented Exome Panels

10. Cardiogenomics Testing Panels Market Regional And Country Analysis

• 10.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiogenomics Testing Panels Market

• 11.1. Asia-Pacific Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiogenomics Testing Panels Market

• 12.1. China Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiogenomics Testing Panels Market

• 13.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiogenomics Testing Panels Market

• 14.1. Japan Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiogenomics Testing Panels Market

• 15.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiogenomics Testing Panels Market

• 16.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiogenomics Testing Panels Market

• 17.1. South Korea Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiogenomics Testing Panels Market

• 18.1. Taiwan Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiogenomics Testing Panels Market

• 19.1. South East Asia Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiogenomics Testing Panels Market

• 20.1. Western Europe Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiogenomics Testing Panels Market

• 21.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiogenomics Testing Panels Market

• 22.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiogenomics Testing Panels Market

• 23.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiogenomics Testing Panels Market

• 24.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiogenomics Testing Panels Market

• 25.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiogenomics Testing Panels Market

• 26.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiogenomics Testing Panels Market

• 27.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiogenomics Testing Panels Market

• 28.1. North America Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiogenomics Testing Panels Market

• 29.1. USA Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiogenomics Testing Panels Market

• 30.1. Canada Cardiogenomics Testing Panels Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiogenomics Testing Panels Market

• 31.1. South America Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiogenomics Testing Panels Market

• 32.1. Brazil Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiogenomics Testing Panels Market

• 33.1. Middle East Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiogenomics Testing Panels Market

• 34.1. Africa Cardiogenomics Testing Panels Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Cardiogenomics Testing Panels Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiogenomics Testing Panels Market Regulatory and Investment Landscape

36. Cardiogenomics Testing Panels Market Competitive Landscape And Company Profiles

• 36.1. Cardiogenomics Testing Panels Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Cardiogenomics Testing Panels Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Cardiogenomics Testing Panels Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

37. Cardiogenomics Testing Panels Market Other Major And Innovative Companies

• Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

38. Global Cardiogenomics Testing Panels Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiogenomics Testing Panels Market

40. Cardiogenomics Testing Panels Market High Potential Countries, Segments and Strategies

• 40.1 Cardiogenomics Testing Panels Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Cardiogenomics Testing Panels Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Cardiogenomics Testing Panels Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer